Researchers at the University Hospital Bonn (UKB) and the University of Bonn have discovered how a small, naturally occurring RNA molecule in the kidney activates a mutated immune receptor, triggering ...
Epitranscriptomics, the study of dynamic co- or post-transcriptional modifications on RNA, has emerged as a vibrant field in ...
The 25th annual Baltimore Running Festival will take place Saturday, bringing widespread road closures, parking restrictions, and commercial vehicle limitations across downtown Baltimore. Resistance ...
Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and author responses to feedback. Transfer RNAs (tRNAs) are ubiquitous ...
In a quest to develop new antiviral drugs for COVID-19 and other diseases, a collaboration led by scientists at The Wertheim UF Scripps Institute has identified a potential new drug against the virus ...
N6-methyladenosine (m6A) is the most prevalent internal modification of eukaryotic mRNA and has emerged as a pivotal regulator of gene expression at the post-transcriptional level. In the tumor immune ...
SEMINOLE COUNTY, Fla. – If you’ve driven down U.S. 17-92 in Seminole County, you’ve probably passed Post Time Lounge and Cafe. It’s been a staple in Longwood for longer than most people can remember, ...
PEOPLE confirmed on Monday, Sept. 29 that the pair split Before the news of their separation, Keith Urban's last Instagram post with Nicole Kidman was in May following the ACM Awards At the country ...
Tylenol did share a post in March 2017 that read, in part, "We actually don't recommend using any of our products while pregnant." However, Tylenol maker Kenvue provided additional context to Snopes ...
Not revised: This Reviewed Preprint includes the authors’ original preprint (without revision), an eLife assessment, public reviews, and a provisional response from the authors. In this manuscript, ...
Turtlemint slipped into the red in the financial year ended March 2025. The insurtech startup posted a net loss of INR 47.1 Cr in FY25 as against a profit of INR 7.4 Cr in the previous year The Mumbai ...
Arnatar Therapeutics has unveiled with $52 million in series A financing to bankroll new RNA-based therapies, including a candidate that takes aim at a rare genetic disease called Alagille syndrome ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback